Shen-Kang protects against tacrolimus-induced renal injury
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Evidence suggests that Shen-Kang (SK), a traditional Chinese herbal medicine, protects against various types of renal injury. In this study, we evaluated whether SK treatment confers renoprotection in a rat model of chronic tacrolimus (TAC) nephropathy. Methods: Rats were treated daily with TAC (1.5 mg/kg, subcutaneously) and SK (450 mg/kg, intravenously) for 4 weeks. The effects of SK on TAC-induced renal injury were assessed by measuring renal function, urine albumin excretion, histopathology, inflammatory cell infiltration, expression of profibrotic (transforming growth factor β1 [TGF-β1] and TGF-β inducible gene-h3 [βig-h3]) and proinflammatory cytokines, oxidative stress, and apoptotic cell death. Results: Administration of SK preserved glomerular integrity (fractional mesangial area and Wilms tumor 1-positive glomeruli), attenuated tubulointerstitial fibrosis, and reduced the number of ectodermal dysplasia 1-positive cells, and this was paralleled by improved urine albumin excretion and renal dysfunction. At the molecular level, SK treatment suppressed expression of TGF-β1/Smad2/3, βig-h3, and proinflammatory cytokines. Oxidative stress and apoptotic cell death were significantly decreased with SK treatment, and apoptosis-related genes were regulated toward cell survival (active caspase-3 and the B-cell lymphoma-2/ Bcl2-associated X [Bcl-2/Bax] ratio). Conclusions: SK protects against TAC-induced renal injury.
Abstract
Background/Aims: Evidence suggests that Shen-Kang (SK), a traditional Chinese herbal medicine, protects against various types of renal injury. In this study, we evaluated whether SK treatment confers renoprotection in a rat model of chronic tacrolimus (TAC) nephropathy. Methods: Rats were treated daily with TAC (1.5 mg/kg, subcutaneously) and SK (450 mg/kg, intravenously) for 4 weeks. The effects of SK on TAC-induced renal injury were assessed by measuring renal function, urine albumin excretion, histopathology, inflammatory cell infiltration, expression of profibrotic (transforming growth factor β1 [TGF-β1] and TGF-β inducible gene-h3 [βig-h3]) and proinflammatory cytokines, oxidative stress, and apoptotic cell death. Results: Administration of SK preserved glomerular integrity (fractional mesangial area and Wilms tumor 1-positive glomeruli), attenuated tubulointerstitial fibrosis, and reduced the number of ectodermal dysplasia 1-positive cells, and this was paralleled by improved urine albumin excretion and renal dysfunction. At the molecular level, SK treatment suppressed expression of TGF-β1/Smad2/3, βig-h3, and proinflammatory cytokines. Oxidative stress and apoptotic cell death were significantly decreased with SK treatment, and apoptosis-related genes were regulated toward cell survival (active caspase-3 and the B-cell lymphoma-2/ Bcl2-associated X [Bcl-2/Bax] ratio). Conclusions: SK protects against TAC-induced renal injury.
참고문헌 (32)
- 임선우, "Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation", The Korean Journal of Internal Medicine, 30(6), pp.759~770 (2015), 대한내과학회[DOI]
- Stratta P, "Posttransplantation chronic renal damage in nonrenal transplant recipients", Kidney Int, 68, pp.1453~1463 (2005)
- Jin J, "Effect of empagliflozin on tacrolimus-induced pancreas islet dysfunction and renal injury", Am J Transplant, 17, pp.2601~2616 (2017)
- JIN JIAN, "Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus- induced diabetic rats", The Korean Journal of Internal Medicine, 32(2), pp.314~322 (2017), 대한내과학회[DOI]
- Lim SW, "Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury", Lab Invest, 95, pp.1174~1185 (2015)
- Liu M, "Shen-Kang protects 5", 6 nephrectomized rats against renal injury by reducing oxidative stress through the MAPK signaling pathways, 2015, pp.36, 975~984
- Xu S, "Inhibitory effects of Shenkang injection and its main component emodin on the proliferation of high glucose-induced renal mesangial cells through cell cycle regulation and induction of apoptosis", Mol Med Rep, 14, pp.3381~3388 (2016)
- Wu X, "ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β", mad3 signalling pathway in vivo and in vitro, 2015, pp.67, 1054~1065
- Zhang YU, "Effect of Shenkang granules on the progression of chronic renal failure in 5", 6 nephrectomized rats, 2015, pp.9, 2034~2042
- Liu Y, "Early renal tubulointerstitial changes and their interventions with Shenkang Injection in diabetic rats", Zhonghua Yi Xue Za Zhi, 95, pp.289~293 (2015)
- Zhang Y, "Effect of Shenkang Injection on kidney function in hypertensive renal damage rats", Zhong Yao Cai, 37, pp.2248~2254 (2014)
- Jin L, "Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats", PLoS One, 9, pp.e100798~ (2014)
- Piao SG, "Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction", Transplantation, 93, pp.383~389 (2012)
- Chung BH, "Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats", Am J Transplant, 5, pp.1856~1867 (2005)
- Li C, "Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy", Am J Physiol Renal Physiol, 286, pp.F46~F57 (2004)
- Lim SW, "Ginseng treatment attenuates autophagic cell death in chronic cyclosporine nephropathy", Nephrology(Carlton), 19, pp.490~499 (2014)
- Al-Harbi NO, "Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue", Biomed Res Int, 2014, pp.607246~ (2014)
- Jin J, "Klotho deficiency aggravates tacrolimus-induced renal injury via the phosphatidylinositol 3-kinase-Akt-Forkhead box protein o pathway", Am J Nephrol, 43, pp.357~365 (2016)
- Li C, "Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal", Acta Pharmacol Sin, 25, pp.401~411 (2004)
- Khanna A, "Tacrolimus and cyclosporinein vitro and in vivo induce osteopontin mRNA and protein expression in renal tissues", Nephron Exp Nephrol, 101, pp.e119~e126 (2005)
- Ophascharoensuk V, "Obstructive uropathy in the mouse : role of osteopontin in interstitial fibrosis and apoptosis", Kidney Int, 56, pp.571~580 (1999)
- Yu XQ, "A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat", Proc Assoc Am Physicians, 110, pp.50~64 (1998)
- Seo JW, "Mycophenolate mofetil ameliorates diabetic nephropathy in db", db mice, 2015, pp.2015, 301627~
- Kuo HL, "IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy", Nephrol Dial Transplant, 33, pp.248~256 (2018)
- Kim JY, "Effect of FTY720 on chronic cyclosporine nephropathy in rats", Transplantation, 80, pp.1323~1330 (2005)
- Shen Y, "N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys", Acta Pharmacol Sin, 37, pp.637~644 (2016)
- Jin H, "Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy", Nephron Exp Nephrol, 126, pp.148~156 (2014)
- Bennett J, "Tacrolimus modulates TGF-β signaling to induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells", J Clin Med, 5, pp.E50~ (2016)
- Agirbasli M, "The blockade of the renin-angiotensin system reverses tacrolimus related cardiovascular toxicity at the histopathological level", J Renin Angiotensin Aldosterone Syst, 8, pp.54~58 (2007)
- Liu X, "Antioxidative stress effects of Salvia przewalskii extract in experimentally injured podocytes", Nephron, 134, pp.253~271 (2016)
- Hisamura F, "Protective effect of green tea extract and tea polyphenols against FK506-induced cytotoxicity in renal cells", Basic Clin Pharmacol Toxicol, 98, pp.192~196 (2006)
- Kim HS, "The protective effect of febuxostat on chronic tacrolimus-induced nephrotoxicity in rats", Nephron, 135, pp.61~71 (2017)